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Extramammary Paget disease (EMPD) is a rare intraepithelial malignancy arising in 
areas rich in apocrine glands such as the vulva, scrotum, penis, perianal region and 
axilla [1]. EMPD usually localizes in the epidermis, but it can also invade into the 
dermis, resulting in lymph node or distant metastases. It is well known that patients with 
advanced malignancies sometimes develop blood coagulation disorders including 
thrombosis [2, 3]. Here, we report the first case of portal and splenic vein embolism in a 
patient with advanced EMPD.  
A 69-year-old woman was referred to us for further evaluation of a 3-year history of 
erythema with focal erosion on the left genital region (figure 1A). We diagnosed it as 
EMPD by a skin biopsy. We performed a wide local excision. Histopathological 
examination showed numerous Paget cells invading into the dermis and permeating into 
lymphatic vessels (figure 1B, 1C and 1D). Ten months after the surgery, she noticed left 
inguinal lymphadenopathy. A lymph node biopsy showed metastasis, but no distant 
metastatic lesion was found by computerized tomography (CT). We performed inguinal 
lymph node dissection, and 7 lymph nodes showed metastases. Three months after the 
lymph node dissection, metastasis in lumbar vertebrae was found. In addition, a few 
weeks later, she had severe abdominalgia. Abdominal ultrasound examination and CT 
revealed portal and splenic vein embolism, splenic infarction, ascites and hepatatrophy 
(figure 1E). A blood coagulation test showed the abnormal levels for D-dimer (20.0 
սg/mL; normal range, <1.0 սg/mL), antithrombin Ⅲ (39%; 80-120%), and fibrinogen 
(152 mg/dL; 170-410mg/dL). Although cytological examination of the ascites did not 
show any neoplastic cells, the serum level of carcinoembryonic antigen (CEA) was 
increased (80.7 ng/mL; <5.0 ng/mL). We started chemotherapy with docetaxel and 
anticoagulant therapy with heparin. The abdominal pain was improved temporarily, and 
CEA (20.8 ng/mL) and D-dimer (12.8 սg/mL) were decreased one month after 
chemotherapy. However, we could not continue the chemotherapy because of her poor 
physical condition. Three months later, abdominal pain reoccurred, but a CT scan showed 
no metastatic lesion except for a bone lesion. A blood examination revealed liver 
dysfunction, and levels of CEA (76.8 ng/mL) and D-dimer (20.7 սg/mL) were increased 
again. Although we continued anticoagulant therapy, her liver function became worse and 
she died 4 months after recognition of the embolism. We did not perform autopsy because 
of her family’s refusal. 
Coagulation abnormalities such as Trousseau’s syndrome, a brain embolism related to 
malignancy, sometimes occur in patients with advanced cancer [2, 3]. Various tumor-
derived factors including tissue factor and mucin are related to the cause of an embolism 
[3]. We consider that the reason for the development of the fatal venous embolism in our 
patient was a hypercoagulative state induced by tumor progression. There was no 
evidence of a metastatic lesion in the abdominal cavity by CT and cytological 
examination of the ascites, and the blood coagulation test showed abnormalities. 
Treatment for an embolism generally includes anticoagulation and excision of the lesion 
[3]. However, it is often difficult to remove the whole malignant lesion. Chemotherapy is 
one of the options for treatment of an embolism in patients with advanced cancer, but it 
can be a risk for the development of another embolism [4]. In our patient, the levels of 
CEA and D-dimer decreased and abdominal pain and ascites were temporarily improved 
after chemotherapy. Therefore, chemotherapy might have been effective for the embolism 
in our patient. 
As far as we know, there has been no previous report of fatal embolisms in a patient with 
EMPD. Generally, portal and splenic vein embolisms can occur in patients with 
malignancies around the portal or splenic vein [5-7]. However, our patient had no 
metastatic lesions around the abdominal cavity. This means that advanced skin cancer can 
also cause portal and splenic embolisms even if the patient does not have a lesion in the 
abdominal cavity. Although it may be difficult to prevent and predict an embolism, if 
patients with advanced skin cancer have abdominal pain without any metastatic lesions 
in the abdominal cavity, a blood coagulation examination should be performed in addition 
to CT and ultrasound examination. If a portal or splenic vein embolism is shown by those 
examinations, we must consider treatment with an anticoagulant and anticancer drug. 
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Figure 1. A) Physical findings. Erythema with erosion in the genital area measuring 5x5 
cm. B) Histopathological findings. Paget cells in the epidermis and dermis (HE staining, 
x100). C) Paget cells invaded into a lymphatic vessel (HE staining, x400). D) Tumor 
cells in the lymphatic vessel (D2-40 staining, x400). E) CT scanning revealed a portal 
vein embolism (yellow arrow) and splenic infarction (red arrow). 
 
 
